DC
ETON icon

Diametric Capital’s Eton Pharmaceutcials ETON Stock Holding History

Diametric Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.87M Sell
156,926
-36,229
-19% -$634K 1.01% 14
2025
Q4 		$3.27M Buy
193,155
+93,846
+94% +$1.65M 0.88% 18
2025
Q3 		$2.16M Buy
99,309
+14,451
+17% +$240K 0.8% 22
2025
Q2 		$1.21M Buy
84,858
+65,261
+333% +$1.03M 0.65% 36
2025
Q1 		$254K Buy
+19,597
New +$296K 0.3% 116
2021
Q2 		– Sell
-49,536
Closed -$363K – 154
2021
Q1 		$363K Sell
49,536
-2,097
-4% -$17.9K 0.28% 87
2020
Q4 		$420K Buy
51,633
+20,484
+66% +$158K 0.33% 90
2020
Q3 		$246K Sell
31,149
-198,670
-86% -$1.36M 0.18% 100
2020
Q2 		$1.25M Sell
229,819
-222,284
-49% -$1.1M 0.96% 38
2020
Q1 		$1.85M Buy
+452,103
New +$2.64M 2.25% 7
2019
Q4 		– Sell
-163,033
Closed -$1.03M – 137
2019
Q3 		$1.03M Buy
163,033
+18,540
+13% +$118K 0.85% 44
2019
Q2 		$1.14M Buy
144,493
+22,620
+19% +$176K 0.72% 49
2019
Q1 		$975K Buy
121,873
+62,871
+107% +$437K 0.77% 52
2018
Q4 		$361K Buy
+59,002
New +$362K 0.28% 83

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Diametric Capital's ETON Position: Q1 2026 in Review

Diametric Capital reduced its Eton Pharmaceutcials (ETON) stake by 19% in Q1 2026, selling an estimated $634K and leaving 156,926 shares worth $3.87M. The position accounts for 1.01% of the portfolio, ranked #14.

Diametric Capital first reported a position in ETON in Q4 2018 and has held it in 14 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Diametric Capital held 156,926 shares of Eton Pharmaceutcials worth $3.87M as of Q1 2026.
  • Diametric Capital sold 36,229 Eton Pharmaceutcials shares in Q1 2026, an estimated $634K.
  • Eton Pharmaceutcials made up 1.01% of Diametric Capital's portfolio in Q1 2026, its #14 holding.
  • Diametric Capital first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 14 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.